OpenClinica EDC: Friendly & Easy to Deploy?
By Cal Collins
OpenClinica has been recognized as the leading Major Contender in the Everest Group's 2024 Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment. Known for its user-friendly interface, strong integration capabilities, and extensive partnerships, OpenClinica stands out in the global EDC landscape. The report highlights OpenClinica’s strengths in ease of use, requiring minimal programming for setup and changes, which simplifies mid-study adjustments, data validation, and query management. OpenClinica’s integration capabilities—such as connectivity with Apple Health, Epic, and Cerner EHR systems, as well as support for SMART on FHIR—further emphasize its adaptability within clinical trials.
Clients have praised OpenClinica for enabling self-reliance in complex study deployment and for its robust support and pricing options, particularly suited to academic and research institutions. The PEAK Matrix report evaluates OpenClinica’s impact in market adoption, portfolio diversity, and value delivered to clients, alongside vision, strategy, and technical sophistication. With its flexible, secure, and scalable infrastructure, OpenClinica is well-positioned to meet diverse clinical trial needs, supported by a partnership network spanning CROs, hospital systems, and industry consortia. This recognition underscores OpenClinica’s commitment to quality, compliance, and innovation in EDC for life sciences.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.